Virginia STEM News
SEE OTHER BRANDS

Daily news on science and technology in Virginia

Virginia STEM News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Virginia STEM News.

Press releases published on May 14, 2025

Red Hen App Successfully Completes Fundraising to Launch Tech-Forward Marketplace for Local Farms

Red Hen App Successfully Completes Fundraising to Launch Tech-Forward Marketplace for Local Farms

Red Hen App, a farmers market in your pocket, is set to launch nationwide this Spring after a successful fundraising campaign with HoneyComb Credit. NEWPORT, VA, UNITED STATES, May 14, 2025 /⁨EINPresswire.com⁩/ -- Red Hen App LLC, a tech-forward …

Homeowner’s Guide Offers Six Easy Tips to Prevent Electrical Fires During National Electrical Safety Month

Homeowner’s Guide Offers Six Easy Tips to Prevent Electrical Fires During National Electrical Safety Month

ARLINGTON, VA, UNITED STATES, May 14, 2025 /⁨EINPresswire.com⁩/ -- Each year more than 40,000 residential electrical fires occur in the U.S., resulting in hundreds of deaths, thousands of injuries and more than a billion dollars in property damage, …

UZIO Launches UZIO.ai: AI-Powered Payroll & HR Agents, empowering SMBs to focus on what matters most

UZIO Launches UZIO.ai: AI-Powered Payroll & HR Agents, empowering SMBs to focus on what matters most

First-of-its-kind AI platform automates repetitive payroll and HR tasks, freeing HR teams to drive culture, talent, and growth GREAT FALLS, VA, UNITED STATES, May 14, 2025 /⁨EINPresswire.com⁩/ -- UZIO, an AI first company, dedicated to turning the promise …

Fedstack lands first Prime GWAC Vehicle under GSA MAS

Fedstack lands first Prime GWAC Vehicle under GSA MAS

Award culminates Fedstack’s services expansion and ability to offer government agencies cost savings and efficiencies as a vetted and trusted partner MCLEAN, VA, UNITED STATES, May 14, 2025 /⁨EINPresswire.com⁩/ -- Fedstack, a technology consulting and …

Nabila Salem Appointed Strategic Advisor to Smoothstack

Nabila Salem Appointed Strategic Advisor to Smoothstack

MCLEAN, VA, UNITED STATES, May 14, 2025 /⁨EINPresswire.com⁩/ -- Smoothstack Inc., a leader in IT solutions and workforce development, is pleased to announce the appointment of Nabila Salem as strategic advisor. This strategic move reinforces Smoothstack’s …

THE BANCORP 48 HOUR DEADLINE ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Deadline in Class Action Lawsuit Against The Bancorp, Inc. - TBBK

THE BANCORP 48 HOUR DEADLINE ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Deadline in Class Action Lawsuit Against The Bancorp, Inc. - TBBK

NEW ORLEANS, May 14, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have only until May 16, 2025 to file lead plaintiff applications in a securities class action lawsuit against The Bancorp, Inc. …

After iOS Traction, AI Pet Travel App Kruiz, Announces Android Launch

After iOS Traction, AI Pet Travel App Kruiz, Announces Android Launch

Irvine, California, May 14, 2025 (GLOBE NEWSWIRE) -- Co-founders Brad Pauer and Angela Le had confirmed—twice—that their dog could fly in-cabin on a trip to London. But a last-minute policy change at Heathrow Airport left them stranded, out thousands of …

Natural Alternatives International, Inc. Announces 2025 Q3 and YTD Results

Natural Alternatives International, Inc. Announces 2025 Q3 and YTD Results

CARLSBAD, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $2.2 million, or $0.37 …

Quorum Announces Q1 2025 Results Release Date, Conference Call and Webcast Details

Quorum Announces Q1 2025 Results Release Date, Conference Call and Webcast Details

CALGARY, Alberta, May 14, 2025 (GLOBE NEWSWIRE) -- Quorum Information Technologies Inc. (TSX-V: QIS) (“Quorum”), a North American SaaS Software and Services company providing essential enterprise solutions that automotive dealerships and Original Equipment …

Updated: Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences

Updated: Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences

SALT LAKE CITY, May 14, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that management plans to participate in the following investor healthcare conferences: …

Jasper Therapeutics to Present at Upcoming Investor Conferences

Jasper Therapeutics to Present at Upcoming Investor Conferences

REDWOOD CITY, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting KIT to address mast cell driven …

Calidi Biotherapeutics Reports First Quarter 2025 Financial Results and Recent Operational Highlights

Calidi Biotherapeutics Reports First Quarter 2025 Financial Results and Recent Operational Highlights

Bolstered management team with hires of Chief Executive Officer and Chief Medical Officer with deep biopharmaceutical experience Announced selection of IL15-superagonist as first payload to be delivered into tumors with Calidi’s first lead candidate using …

Eton Pharmaceuticals to Participate at Upcoming Investor Conferences

Eton Pharmaceuticals to Participate at Upcoming Investor Conferences

DEER PARK, Ill., May 14, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that Sean …

FibroBiologics Reports First Quarter 2025 Financial Results and Provides Corporate Update

FibroBiologics Reports First Quarter 2025 Financial Results and Provides Corporate Update

HOUSTON, May 14, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending for the development of therapeutics and potential cures for chronic diseases using …

Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results

Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results

TORONTO, May 14, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the three and …

Oruka Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Oruka Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Continued operational excellence leading to acceleration of multiple timelines: ORKA-001, targeting IL-23p19, Phase 1 trial dosing complete, with data expected in 3Q 2025 ORKA-001 Phase 2a initiation expected in 2H 2025, with efficacy readout expected in …

HP Inc. Declares Dividend

HP Inc. Declares Dividend

PALO ALTO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- HP Inc. (NYSE: HPQ) has declared a cash dividend of $0.2894 per share on the company’s common stock. The dividend, the third in HP’s fiscal year 2025, is payable on July 2, 2025, to stockholders of record …

X4 Pharmaceuticals Announces Upcoming Presentation of Phase 2 Chronic Neutropenia Trial Data at the 30th Annual EHA Congress

X4 Pharmaceuticals Announces Upcoming Presentation of Phase 2 Chronic Neutropenia Trial Data at the 30th Annual EHA Congress

Meaningful and durable increases in functional neutrophils observed over 6-month trial with oral once-daily mavorixafor Majority of physicians and chronic neutropenia participants chose to significantly reduce G-CSF dosing when using mavorixafor in …

GENFIT: Publication of the 2025 Extra-Financial Performance Report (fiscal year 2024)

GENFIT: Publication of the 2025 Extra-Financial Performance Report (fiscal year 2024)

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 14, 2025- GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today …

GENFIT : Publication du rapport de performance extra-financière 2025 (exercice 2024)

GENFIT : Publication du rapport de performance extra-financière 2025 (exercice 2024)

Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 14 mai 2025 – GENFIT (Nasdaq et Euronext : GNFT), société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies rares du foie pouvant engager le …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service